Skip to main navigation Skip to search Skip to main content

Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs

  • Albert Einstein College of Medicine
  • Cornell University

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We have designed and synthesized a small library of 3,5-disubstituted-1,2, 4-oxadiazole containing combretastatin A-4 (CA-4) analogs. Our objective is to increase the efficacy of the CA-4 as an anti-tubulin and antimitotic agent by substituting the cis-alkene bond with one of its bioisosteres, the 1,2,4-oxadiazole ring. We also modified the substituents attached to both of the phenyl rings (ring A and B in Fig. 1) of CA-4 for the purpose of diversifying our analogs based on SAR. These compounds were synthesized via a coupling reaction between an amidoxime and a carboxylic acid in DMF solvent, with HOBt as a base, and utilizing EDCI as a coupling reagent. Using this protocol, we synthesized a small library of 10 compounds with moderate to good yields. A detailed biological study is currently undergoing in our laboratory to evaluate the activity of these compounds.

Original languageEnglish
Pages (from-to)3947-3950
Number of pages4
JournalTetrahedron Letters
Volume53
Issue number31
DOIs
StatePublished - Aug 1 2012

Keywords

  • 3,5-Disubstituted 1,2,4-oxadiazole
  • Bioisosteres
  • Boron-containing CA4 compound
  • Combretastatin A-4
  • Tubulin
  • Vascular disrupting agent

Fingerprint

Dive into the research topics of 'Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs'. Together they form a unique fingerprint.

Cite this